Literature DB >> 4169739

Immunohistochemical study of allergic encephalomyelitis.

M B Oldstone, F J Dixon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 4169739      PMCID： PMC2013335     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN： 0002-9440            Impact factor:   4.307


× No keyword cloud information.
  10 in total

1.  GUINEA PIG BETA-1C-GLOBULIN: ITS RELATIONSHIP TO THE THIRD COMPONENT OF COMPLEMENT AND ITS ALTERATION FOLLOWING INTERACTION WITH IMMUNE COMPLEXES.

Authors:  W D LINSCOTT; C G COCHRANE
Journal:  J Immunol       Date:  1964-12       Impact factor: 5.422

2.  A histologic study of the early lesion in experimental allergic encephalomyelitis in the guinea pig and rabbit.

Authors:  B H WAKSMAN; R D ADAMS
Journal:  Am J Pathol       Date:  1962-08       Impact factor: 4.307

3.  Superiority of fluorescein isothiocyanate (Riggs) for fluorescent-antibody technic with a modification of its application.

Authors:  J D MARSHALL; W C EVELAND; C W SMITH
Journal:  Proc Soc Exp Biol Med       Date:  1958 Aug-Sep

4.  Further study of skin reactions in rabbits with experimental allergic encephalomyelitis: reactions to tests with purified white matter fractions; use of a quantitative technique for evaluating sensitivity production of sensitization and disease by intradermal injection of antigen without adjuvants.

Authors:  B H WAKSMAN
Journal:  J Infect Dis       Date:  1956 Nov-Dec       Impact factor: 5.226

5.  A study of abnormal blood-brain permeability in experimental allergic encephalomyelitis.

Authors:  C F BARLOW
Journal:  J Neuropathol Exp Neurol       Date:  1956-04       Impact factor: 3.685

6.  Tuberculin type sensitivity to spinal cord antigen in rabbits with isoallergic encephalomyelitis.

Authors:  B H WAKSMAN; L R MORRISON
Journal:  J Immunol       Date:  1951-04       Impact factor: 5.422

7.  Brain vascular permeability to I-125 gamma globulin and leukocytes in allergic encephalomyelitis.

Authors:  R W Cutler; A V Lorenzo; C F Barlow
Journal:  J Neuropathol Exp Neurol       Date:  1967-10       Impact factor: 3.685

8.  THE APPLICATION OF TISSUE CULTURE TO THE STUDY OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS. II. SERUM FACTORS RESPONSIBLE FOR DEMYELINATION.

Authors:  S H APPEL; M B BORNSTEIN
Journal:  J Exp Med       Date:  1964-02-01       Impact factor: 14.307

9.  Transfer of allergic encephalomyelitis in rats by means of lymph node cells.

Authors:  P Y PATERSON
Journal:  J Exp Med       Date:  1960-01-01       Impact factor: 14.307

10.  EXPERIMENTAL GLOMERULONEPHRITIS. IV. PARTICIPATION OF COMPLEMENT IN NEPHROTOXIC NEPHRITIS.

Authors:  E UNANUE; F J DIXON
Journal:  J Exp Med       Date:  1964-01-01       Impact factor: 14.307
  10 in total
  36 in total

1.  Antigen-induced monocyte procoagulant activity. Requirement for antigen presentation and histocompatibility leukocyte antigen-DR molecules.

Authors:  B S Schwartz
Journal:  J Clin Invest       Date:  1985-09       Impact factor: 14.808

2.  The immunopathology of acute experimental allergic encephalomyelitis. V. A light microscopic and ultrastructural immunohistochemical analysis of fibronectin and fibrinogen.

Authors:  R A Sobel; E E Schneeberger; R B Colvin
Journal:  Am J Pathol       Date:  1988-06       Impact factor: 4.307

3.  Simultaneous visualization of vascular permeability change and leukocyte egress in the central nervous system during autoimmune encephalomyelitis.

Authors:  R D Simmons; T M Buzbee; D S Linthicum; W J Mandy; G Chen; C Wang
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

Review 4.  Hyperacute, neutrophilic, and localized forms of experimental allergic encephalomyelitis: a review.

Authors:  S Levine
Journal:  Acta Neuropathol       Date:  1974       Impact factor: 17.088

5.  Cerebral vascular permeability and cellular infiltration in experimental allergic encephalomyelitis.

Authors:  S Leibowitz; L Kennedy
Journal:  Immunology       Date:  1972-05       Impact factor: 7.397

6.  The clotting system: gatekeeper of cerebrovascular permeability and monitor of clinical manifestations of neuroautoimmune disease.

Authors:  P Y Paterson; J Gausas; C S Koh; H C Kwaan
Journal:  Trans Am Clin Climatol Assoc       Date:  1986

Review 7.  Characterization and distribution of lymphocyte subpopulations in multiple sclerosis plaques versus autoimmune demyelinating lesions.

Authors:  U Traugott
Journal:  Springer Semin Immunopathol       Date:  1985

8.  Insulin-like growth factor I treatment reduces demyelination and up-regulates gene expression of myelin-related proteins in experimental autoimmune encephalomyelitis.

Authors:  D L Yao; X Liu; L D Hudson; H D Webster
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

9.  The effect of antisera against rat immunoglobulins on cellular transfer of experimental allergic encephalomyelitiin Lewis rats.

Authors:  W P Richardson; P Y Paterson
Journal:  Clin Exp Immunol       Date:  1970-03       Impact factor: 4.330

10.  Targeted inhibition of complement using complement receptor 2-conjugated inhibitors attenuates EAE.

Authors:  Xianzhen Hu; Stephen Tomlinson; Scott R Barnum
Journal:  Neurosci Lett       Date:  2012-10-16       Impact factor: 3.046
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.